ICON plc, a Dublin-based global provider of drug development solutions and biotechnical, pharmaceutical, and medical device services, announced in October that Irish America Business 100 honoree Ciaran Murray will transition from the role of company CEO to chairman of the board of directors, effective March 2017.
Acting chairman Declan McKeon thanked Murray (right) for his work as CEO, saying that since 2011, “Ciaran has led ICON through a transformative phase of our development which has seen the company deliver outstanding financial and operational performance and broaden its strategic capabilities.”
“Through our focus on innovation, investment in talent and by continuing to enhance and broaden our service capabilities, we have driven significant growth and shareholder value,” Murray said in his official statement. “The last five years as ICON’s CEO have been the most exciting and fulfilling of my professional career.” ♦
Leave a Reply